Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Urological cancers and lifestyle: Nudging patients toward healthy behaviors.

Parsons JK.

Urol Oncol. 2019 Mar 28. pii: S1078-1439(19)30009-2. doi: 10.1016/j.urolonc.2019.01.008. [Epub ahead of print] Review.

PMID:
30930098
2.

Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer.

Bryant AK, McKay RR, Kader AK, Parsons JK, Einck JP, Kane CJ, Mundt AJ, Murphy JD, Rose BS.

Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1068-1076. doi: 10.1016/j.ijrobp.2018.12.001. Epub 2018 Dec 11.

PMID:
30543857
3.

A Randomized, Double-blind, Phase II Trial of PSA-TRICOM (PROSTVAC) in Patients with Localized Prostate Cancer: The Immunotherapy to Prevent Progression on Active Surveillance Study.

Parsons JK, Pinto PA, Pavlovich CP, Uchio E, Kim HL, Nguyen MN, Gulley JL, Jamieson C, Hsu P, Wojtowicz M, Parnes H, Schlom J, Dahut WL, Madan RA, Donahue RN, Chow HS.

Eur Urol Focus. 2018 Sep;4(5):636-638. doi: 10.1016/j.euf.2018.08.016. Epub 2018 Sep 7.

PMID:
30197041
4.

The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.

Pacyna JE, Kim S, Yost K, Sedlacek H, Petereit D, Kaur J, Rapkin B, Grubb R, Paskett E, Chang GJ, Sloan J, Basch E, Major B, Novotny P, Taylor J, Buckner J, Parsons JK, Morris M, Tilburt JC.

BMC Cancer. 2018 Aug 6;18(1):788. doi: 10.1186/s12885-018-4672-3.

5.

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline.

Foster HE, Barry MJ, Dahm P, Gandhi MC, Kaplan SA, Kohler TS, Lerner LB, Lightner DJ, Parsons JK, Roehrborn CG, Welliver C, Wilt TJ, McVary KT.

J Urol. 2018 Sep;200(3):612-619. doi: 10.1016/j.juro.2018.05.048. Epub 2018 Jun 11.

PMID:
29775639
6.

Salvage image guided radiation therapy to the prostate after cryotherapy failure.

Hopper AB, Sandhu APS, Parsons JK, Rose B, Einck JP.

Adv Radiat Oncol. 2017 Sep 27;3(1):52-56. doi: 10.1016/j.adro.2017.09.001. eCollection 2018 Jan-Mar.

7.

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.

Seibert TM, Fan CC, Wang Y, Zuber V, Karunamuni R, Parsons JK, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Garcia SB, Muir K, Grönberg H, Wiklund F, Aly M, Schleutker J, Sipeky C, Tammela TL, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Cuk K, Saum KU, Park JY, Sellers TA, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Karow DS, Mills IG, Andreassen OA, Dale AM; PRACTICAL Consortium*.

BMJ. 2018 Jan 10;360:j5757. doi: 10.1136/bmj.j5757.

8.

Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.

Watts EL, Appleby PN, Albanes D, Black A, Chan JM, Chen C, Cirillo PM, Cohn BA, Cook MB, Donovan JL, Ferrucci L, Garland CF, Giles GG, Goodman PJ, Habel LA, Haiman CA, Holly JMP, Hoover RN, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luostarinen T, MacInnis RJ, Mäenpää HO, Männistö S, Metter EJ, Milne RL, Nomura AMY, Oliver SE, Parsons JK, Peeters PH, Platz EA, Riboli E, Ricceri F, Rinaldi S, Rissanen H, Sawada N, Schaefer CA, Schenk JM, Stanczyk FZ, Stampfer M, Stattin P, Stenman UH, Tjønneland A, Trichopoulou A, Thompson IM, Tsugane S, Vatten L, Whittemore AS, Ziegler RG, Allen NE, Key TJ, Travis RC.

PLoS One. 2017 Dec 27;12(12):e0187741. doi: 10.1371/journal.pone.0187741. eCollection 2017.

9.

Physical Activity Decreases Kidney Cancer Mortality.

Liss M, Natarajan L, Hasan A, Noguchi JL, White M, Parsons JK.

Curr Urol. 2017 Nov;10(4):193-198. doi: 10.1159/000447180. Epub 2017 Oct 22.

10.

Nutrition, physical activity, and lifestyle factors in prostate cancer prevention.

Ballon-Landa E, Parsons JK.

Curr Opin Urol. 2018 Jan;28(1):55-61. doi: 10.1097/MOU.0000000000000460. Review.

PMID:
29049045
11.

Dietary Antioxidants and Longitudinal Changes in Lower Urinary Tract Symptoms in Elderly Men: The Osteoporotic Fractures in Men Study.

Holton KF, Marshall LM, Shannon J, Lapidus JA, Shikany JM, Bauer DC, Barrett-Connor E, Parsons JK; Osteoporotic Fractures in Men Study Group.

Eur Urol Focus. 2016 Aug;2(3):310-318. doi: 10.1016/j.euf.2015.09.006. Epub 2015 Sep 26.

12.

Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer.

Parsons JK, Pierce JP, Mohler J, Paskett E, Jung SH, Morris MJ, Small E, Hahn O, Humphrey P, Taylor J, Marshall J.

BJU Int. 2018 Apr;121(4):534-539. doi: 10.1111/bju.13890. Epub 2017 May 21.

13.

Surgical Options for the Enlarged, Obstructing, Benign Prostate.

Parsons JK.

J Urol. 2017 Apr;197(4):977-978. doi: 10.1016/j.juro.2017.01.052. Epub 2017 Jan 21. No abstract available.

PMID:
28113060
14.

Exercise Decreases and Smoking Increases Bladder Cancer Mortality.

Liss MA, White M, Natarajan L, Parsons JK.

Clin Genitourin Cancer. 2017 Jun;15(3):391-395. doi: 10.1016/j.clgc.2016.11.006. Epub 2016 Dec 1.

15.

Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review?

Solomon JP, Lowenthal BM, Kader AK, Parsons JK, Flaig TW, Siefker-Radtke AO, Dyrskjøt L, Hansel DE.

Urology. 2017 Apr;102:7-16. doi: 10.1016/j.urology.2016.10.014. Epub 2016 Oct 18. Review.

PMID:
27769917
16.

Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.

Brunsing RL, Schenker-Ahmed NM, White NS, Parsons JK, Kane C, Kuperman J, Bartsch H, Kader AK, Rakow-Penner R, Seibert TM, Margolis D, Raman SS, McDonald CR, Farid N, Kesari S, Hansel D, Shabaik A, Dale AM, Karow DS.

J Magn Reson Imaging. 2017 Feb;45(2):323-336. doi: 10.1002/jmri.25419. Epub 2016 Aug 16. Review.

17.

Robotic-Assisted Simple Prostatectomy: An Overview.

Holden M, Parsons JK.

Urol Clin North Am. 2016 Aug;43(3):385-91. doi: 10.1016/j.ucl.2016.04.007. Review.

PMID:
27476131
18.

Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.

Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Bhasin S, Matsumoto AM, Parsons JK, Gill TM, Molitch ME, Farrar JT, Cella D, Barrett-Connor E, Cauley JA, Cifelli D, Crandall JP, Ensrud KE, Gallagher L, Zeldow B, Lewis CE, Pahor M, Swerdloff RS, Hou X, Anton S, Basaria S, Diem SJ, Tabatabaie V, Ellenberg SS, Snyder PJ.

J Clin Endocrinol Metab. 2016 Aug;101(8):3096-104. doi: 10.1210/jc.2016-1645. Epub 2016 Jun 29.

19.

Voxel Level Radiologic-Pathologic Validation of Restriction Spectrum Imaging Cellularity Index with Gleason Grade in Prostate Cancer.

Yamin G, Schenker-Ahmed NM, Shabaik A, Adams D, Bartsch H, Kuperman J, White NS, Rakow-Penner RA, McCammack K, Parsons JK, Kane CJ, Dale AM, Karow DS.

Clin Cancer Res. 2016 Jun 1;22(11):2668-74. doi: 10.1158/1078-0432.CCR-15-2429.

20.

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.

Carroll PR, Parsons JK, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP 3rd, Kawachi MH, Kim S, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Moses KA, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenkle P, Vickers AJ, Wake R, Shead DA, Freedman-Cass DA.

J Natl Compr Canc Netw. 2016 May;14(5):509-19.

PMID:
27160230
21.

Prostate Cancer Prevention: Concepts and Clinical Trials.

Hamilton Z, Parsons JK.

Curr Urol Rep. 2016 Apr;17(4):35. doi: 10.1007/s11934-016-0587-1. Review.

PMID:
26957512
22.

Editorial Comment.

Parsons JK.

J Urol. 2016 May;195(5):1538. doi: 10.1016/j.juro.2015.10.196. Epub 2016 Feb 23. No abstract available.

PMID:
26916474
23.

Restriction spectrum imaging improves MRI-based prostate cancer detection.

McCammack KC, Schenker-Ahmed NM, White NS, Best SR, Marks RM, Heimbigner J, Kane CJ, Parsons JK, Kuperman JM, Bartsch H, Desikan RS, Rakow-Penner RA, Liss MA, Margolis DJ, Raman SS, Shabaik A, Dale AM, Karow DS.

Abdom Radiol (NY). 2016 May;41(5):946-53. doi: 10.1007/s00261-016-0659-1.

24.

Lower Urinary Tract Symptoms and Risk of Nonspine Fractures among Older Community Dwelling U.S. Men.

Marshall LM, Lapidus JA, Wiedrick J, Barrett-Connor E, Bauer DC, Orwoll ES, Parsons JK; Osteoporotic Fractures in Men (MrOS) Research Group.

J Urol. 2016 Jul;196(1):166-72. doi: 10.1016/j.juro.2016.02.081. Epub 2016 Feb 22.

25.

Effects of Testosterone Treatment in Older Men.

Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Cifelli D, Dougar D, Fluharty L, Resnick SM, Storer TW, Anton S, Basaria S, Diem SJ, Hou X, Mohler ER 3rd, Parsons JK, Wenger NK, Zeldow B, Landis JR, Ellenberg SS; Testosterone Trials Investigators.

N Engl J Med. 2016 Feb 18;374(7):611-24. doi: 10.1056/NEJMoa1506119.

26.

The Case for Tailored Prostate Cancer Screening: An NCCN Perspective.

McDonald ML, Parsons JK.

J Natl Compr Canc Netw. 2015 Dec;13(12):1576-83. Review.

PMID:
26656524
27.

NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015.

Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP 3rd, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenke P, Vickers AJ, Wake R, Shead DA, Freedman-Cass D.

J Natl Compr Canc Netw. 2015 Dec;13(12):1534-61.

PMID:
26656522
28.

4-Kallikrein Test and Kallikrein Markers in Prostate Cancer Screening.

McDonald ML, Parsons JK.

Urol Clin North Am. 2016 Feb;43(1):39-46. doi: 10.1016/j.ucl.2015.08.004. Review.

PMID:
26614027
29.

Obesity, Physical Activity and Bladder Cancer.

Noguchi JL, Liss MA, Parsons JK.

Curr Urol Rep. 2015 Oct;16(10):74. doi: 10.1007/s11934-015-0546-2. Review.

PMID:
26303776
30.

A Family History of Lethal Prostate Cancer and Risk of Aggressive Prostate Cancer in Patients Undergoing Radical Prostatectomy.

Raheem OA, Cohen SA, Parsons JK, Palazzi KL, Kane CJ.

Sci Rep. 2015 Jun 26;5:10544. doi: 10.1038/srep10544.

31.

A National, Comparative Analysis of Perioperative Outcomes of Open and Minimally Invasive Simple Prostatectomy.

Parsons JK, Rangarajan SS, Palazzi K, Chang D.

J Endourol. 2015 Aug;29(8):919-24. doi: 10.1089/end.2014.0879. Epub 2015 Apr 15.

PMID:
25793265
32.

MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens.

Liss MA, White NS, Parsons JK, Schenker-Ahmed NM, Rakow-Penner R, Kuperman JM, Bartsch H, Choi HW, Mattrey RF, Bradley WG, Shabaik A, Huang J, Margolis DJ, Raman SS, Marks LS, Kane CJ, Reiter RE, Dale AM, Karow DS.

Front Oncol. 2015 Feb 17;5:30. doi: 10.3389/fonc.2015.00030. eCollection 2015.

33.

Faulty analysis in study of robotic-assisted minimally invasive radical prostatectomy—reply.

Parsons JK, Chang D.

JAMA Surg. 2015 Apr;150(4):372. doi: 10.1001/jamasurg.2015.45. No abstract available.

PMID:
25714658
34.

Hospital-based trends in penile prosthetic surgery.

Mirheydar HS, Palazzi KL, Parsons JK, Chang D, Hsieh TC.

J Sex Med. 2015 Apr;12(4):1092-8. doi: 10.1111/jsm.12829. Epub 2015 Feb 9.

PMID:
25664424
35.

Prostate laser vaporization is safe and effective in elderly men.

Majumdar R, Mirheydar HS, Palazzi KL, Lakin CM, Albo ME, Parsons JK.

Urol Ann. 2015 Jan-Mar;7(1):36-40. doi: 10.4103/0974-7796.148595.

36.

Novel biomarkers and advanced imaging modalities in the early detection of prostate cancer.

Parsons JK.

J Urol. 2015 Apr;193(4):1084-5. doi: 10.1016/j.juro.2015.01.040. Epub 2015 Jan 14. No abstract available.

PMID:
25596362
37.

Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses.

Liss MA, Wang S, Palazzi K, Jabaji R, Patel N, Lee HJ, Parsons JK, Derweesh IH.

BMC Urol. 2014 Dec 17;14:101. doi: 10.1186/1471-2490-14-101.

38.

Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European-American Multi-institutional Analysis.

Autorino R, Zargar H, Mariano MB, Sanchez-Salas R, Sotelo RJ, Chlosta PL, Castillo O, Matei DV, Celia A, Koc G, Vora A, Aron M, Parsons JK, Pini G, Jensen JC, Sutherland D, Cathelineau X, Nuñez Bragayrac LA, Varkarakis IM, Amparore D, Ferro M, Gallo G, Volpe A, Vuruskan H, Bandi G, Hwang J, Nething J, Muruve N, Chopra S, Patel ND, Derweesh I, Champ Weeks D, Spier R, Kowalczyk K, Lynch J, Harbin A, Verghese M, Samavedi S, Molina WR, Dias E, Ahallal Y, Laydner H, Cherullo E, De Cobelli O, Thiel DD, Lagerkvist M, Haber GP, Kaouk J, Kim FJ, Lima E, Patel V, White W, Mottrie A, Porpiglia F.

Eur Urol. 2015 Jul;68(1):86-94. doi: 10.1016/j.eururo.2014.11.044. Epub 2014 Dec 4.

39.

Laparoscopic appendectomy is safer than open appendectomy in an elderly population.

Ward NT, Ramamoorthy SL, Chang DC, Parsons JK.

JSLS. 2014 Jul-Sep;18(3). pii: e2014.00322. doi: 10.4293/JSLS.2014.00322.

40.

Unclassified mucinous renal cell carcinoma: a rare histopathological entity.

Raheem OA, Godebu E, Cohen SA, Shabaik A, Parsons JK.

Korean J Urol. 2014 Oct;55(10):690-2. doi: 10.4111/kju.2014.55.10.690. Epub 2014 Oct 10.

41.

Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.

Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP 3rd, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shanefelt TM, Vickers AJ, Wake R, Shead DA, Ho M; National comprehensive cancer network.

J Natl Compr Canc Netw. 2014 Sep;12(9):1211-9; quiz 1219.

PMID:
25190691
42.

Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging.

White NS, McDonald C, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjørnerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons JK, Chen CC, Raman S, Margolis D, Reiter RE, Marks L, Kesari S, Mundt AJ, Kane CJ, Carter BS, Bradley WG, Dale AM.

Cancer Res. 2014 Sep 1;74(17):4638-52. doi: 10.1158/0008-5472.CAN-13-3534. Review. Erratum in: Cancer Res. 2014 Nov 15;74(22):6733. McDonald, Carrie R [corrected to McDonald, Carrie];Kaine, Christopher J [corrected to Kane, Christopher J].

43.

Robotic-assisted simple prostatectomy: is there evidence to go beyond the experimental stage?

Patel ND, Parsons JK.

Curr Urol Rep. 2014 Oct;15(10):443. doi: 10.1007/s11934-014-0443-0. Review.

PMID:
25118852
44.

Diffusion of surgical innovations, patient safety, and minimally invasive radical prostatectomy.

Parsons JK, Messer K, Palazzi K, Stroup SP, Chang D.

JAMA Surg. 2014 Aug;149(8):845-51. doi: 10.1001/jamasurg.2014.31. Erratum in: JAMA Surg. 2014 Sep;149(9):961.

45.

Reply: To PMID 24958477.

Cohen SA, Mirheydar HS, Parsons JK, Palazzi KL, Liss MA, Chang DC, Kane CJ, Kader AK.

Urology. 2014 Aug;84(2):319-20. doi: 10.1016/j.urology.2014.02.053. Epub 2014 Jun 21. No abstract available.

PMID:
24958489
46.

Minimally invasive cystectomy is associated with improved perioperative patient safety outcomes compared with open cystectomy in a national cohort.

Cohen SA, Mirheydar HS, Parsons JK, Palazzi KL, Liss MA, Chang DC, Kane CJ, Kader AK.

Urology. 2014 Aug;84(2):314-9. doi: 10.1016/j.urology.2014.02.048. Epub 2014 Jun 21.

PMID:
24958477
47.

Primary mucin-producing urothelial-type adenocarcinoma of the prostatic urethra diagnosed on TURP: a case report and review of literature.

Sebesta EM, Mirheydar HS, Parsons JK, Wang-Rodriguez J, Kader AK.

BMC Urol. 2014 May 22;14:39. doi: 10.1186/1471-2490-14-39. Review.

48.

A randomized trial of diet in men with early stage prostate cancer on active surveillance: rationale and design of the Men's Eating and Living (MEAL) Study (CALGB 70807 [Alliance]).

Parsons JK, Pierce JP, Mohler J, Paskett E, Jung SH, Humphrey P, Taylor JR, Newman VA, Barbier L, Rock CL, Marshall J.

Contemp Clin Trials. 2014 Jul;38(2):198-203. doi: 10.1016/j.cct.2014.05.002. Epub 2014 May 13.

49.

Candidate SNP associations of optimism and resilience in older adults: exploratory study of 935 community-dwelling adults.

Rana BK, Darst BF, Bloss C, Shih PA, Depp C, Nievergelt CM, Allison M, Parsons JK, Schork N, Jeste DV.

Am J Geriatr Psychiatry. 2014 Oct;22(10):997-1006.e5. doi: 10.1016/j.jagp.2014.03.009. Epub 2014 Mar 26.

50.

Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction.

Patel ND, Parsons JK.

Indian J Urol. 2014 Apr;30(2):170-6. doi: 10.4103/0970-1591.126900.

Supplemental Content

Loading ...
Support Center